Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
2.650
-0.140 (-5.02%)
Mar 9, 2026, 2:04 PM EDT - Market open
Organogenesis Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 563.03 | 482.04 | 433.14 | 450.89 | 467.36 | Upgrade
|
| Other Revenue | 1.14 | - | - | - | - | Upgrade
|
| Revenue | 564.17 | 482.04 | 433.14 | 450.89 | 467.36 | Upgrade
|
| Revenue Growth (YoY) | 17.04% | 11.29% | -3.94% | -3.52% | 38.15% | Upgrade
|
| Cost of Revenue | 137.52 | 115.74 | 106.48 | 105.02 | 114.2 | Upgrade
|
| Gross Profit | 426.65 | 366.3 | 326.66 | 345.87 | 353.16 | Upgrade
|
| Selling, General & Admin | 325.72 | 294.51 | 265.96 | 281.54 | 249.48 | Upgrade
|
| Research & Development | 44.54 | 50.27 | 44.38 | 39.76 | 30.74 | Upgrade
|
| Operating Expenses | 370.26 | 344.78 | 310.34 | 321.3 | 280.22 | Upgrade
|
| Operating Income | 56.39 | 21.52 | 16.32 | 24.57 | 72.94 | Upgrade
|
| Interest Expense | - | -1.54 | -2.19 | -2.01 | -7.24 | Upgrade
|
| Interest & Investment Income | 2.28 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.01 | 0.02 | 0.06 | -0.01 | -0.01 | Upgrade
|
| EBT Excluding Unusual Items | 58.66 | 19.99 | 14.19 | 22.55 | 65.69 | Upgrade
|
| Merger & Restructuring Charges | -0.52 | - | -3.8 | -2.27 | -4.7 | Upgrade
|
| Gain (Loss) on Sale of Assets | -11.18 | - | - | - | - | Upgrade
|
| Asset Writedown | - | -22.8 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 2.1 | Upgrade
|
| Pretax Income | 46.97 | -2.81 | 10.39 | 20.28 | 63.09 | Upgrade
|
| Income Tax Expense | 9.94 | -3.67 | 5.45 | 4.75 | -31.12 | Upgrade
|
| Earnings From Continuing Operations | 37.03 | 0.86 | 4.95 | 15.53 | 94.2 | Upgrade
|
| Net Income | 37.03 | 0.86 | 4.95 | 15.53 | 94.2 | Upgrade
|
| Preferred Dividends & Other Adjustments | 17.01 | 1.8 | - | - | - | Upgrade
|
| Net Income to Common | 20.02 | -0.94 | 4.95 | 15.53 | 94.2 | Upgrade
|
| Net Income Growth | 4201.05% | -82.59% | -68.16% | -83.51% | 446.61% | Upgrade
|
| Shares Outstanding (Basic) | 127 | 132 | 131 | 130 | 128 | Upgrade
|
| Shares Outstanding (Diluted) | 130 | 132 | 133 | 132 | 134 | Upgrade
|
| Shares Change (YoY) | -1.08% | -0.81% | 0.27% | -0.96% | 20.03% | Upgrade
|
| EPS (Basic) | 0.16 | -0.01 | 0.04 | 0.12 | 0.73 | Upgrade
|
| EPS (Diluted) | 0.15 | -0.01 | 0.04 | 0.12 | 0.70 | Upgrade
|
| EPS Growth | - | - | -68.44% | -82.94% | 366.67% | Upgrade
|
| Free Cash Flow | -24.46 | 4.18 | 6.55 | -9.04 | 30.76 | Upgrade
|
| Free Cash Flow Per Share | -0.19 | 0.03 | 0.05 | -0.07 | 0.23 | Upgrade
|
| Gross Margin | 75.62% | 75.99% | 75.42% | 76.71% | 75.56% | Upgrade
|
| Operating Margin | 9.99% | 4.46% | 3.77% | 5.45% | 15.61% | Upgrade
|
| Profit Margin | 3.55% | -0.19% | 1.14% | 3.45% | 20.16% | Upgrade
|
| Free Cash Flow Margin | -4.34% | 0.87% | 1.51% | -2.00% | 6.58% | Upgrade
|
| EBITDA | 74.98 | 38.54 | 31.69 | 35.3 | 83.67 | Upgrade
|
| EBITDA Margin | 13.29% | 8.00% | 7.32% | 7.83% | 17.90% | Upgrade
|
| D&A For EBITDA | 18.6 | 17.03 | 15.37 | 10.73 | 10.73 | Upgrade
|
| EBIT | 56.39 | 21.52 | 16.32 | 24.57 | 72.94 | Upgrade
|
| EBIT Margin | 9.99% | 4.46% | 3.77% | 5.45% | 15.61% | Upgrade
|
| Effective Tax Rate | 21.16% | - | 52.41% | 23.42% | - | Upgrade
|
| Revenue as Reported | 564.17 | 482.04 | 433.14 | - | - | Upgrade
|
| Advertising Expenses | 5.84 | 3.83 | 5.23 | 4.81 | 5.52 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.